Health
A molecular trap against COVID-19 – Science Magazine
The cell surface peptidase angiotensin-converting enzyme 2 (ACE2) is the primary receptor for the spike (S) fusion protein that facilitates cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous studies are evaluating therapeutic…
The cell surface peptidase angiotensin-converting enzyme 2 (ACE2) is the primary receptor for the spike (S) fusion protein that facilitates cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous studies are evaluating therapeutic and preventive treatments that block S protein interactions with ACE2 molecules that are expressed on host cells. For example, the ACE2 binding site can be occluded by monoclonal antibodies, several of which are rapidly advancing in clinica…
-
General20 hours agoHundreds gather in Gin Gin at vigil for allegedly murdered teen Pheobe Bishop
-
General17 hours ago‘Miracle’ PM gets top gong in the name of the King
-
Noosa News22 hours agoDaly Cherry-Evans set to be dropped as Maroons captain
-
Noosa News21 hours agoThe Story Bridge should serve as a warning – and an opportunity